Nicholas B. Argento, MD, CDTC
Director of Diabetes Technology
Director of Electronic Health Record System
Maryland Endocrine, PA
Nicholas B. Argento
training in Internal Medicine, and then in Diabetes, Endocrine and Metabolism at the University of Maryland Medical System
He is currently a senior partner at a 10 physician diabetes and endocrinology practice, Maryland Endocrine PA, where he serves as the Director of Diabetes Technology, Director of the Electronic Health Record System, and Clinical Laboratory Director.
He is a Certified Diabetes Technology Clinician.
He serves as the Medical Advisor to the Diabetes Program at Howard County General Hospital in Columbia, Maryland, a 250-bed Johns Hopkins System Community Hospital, and is participating in efforts to improve and standardize diabetes protocols across the hospitals in the Johns Hopkins Hospital System.
Having had type 1 diabetes since 1968, he
is dedicated to providing state of the art diabetes care to both type 1 and type 2 patients.
has led the effort at his
practice to fully incorporate recent advances in diabetes technology into clinical practice, including extensive use of insulin pumps and continuous glucose monitoring (CGM).
has spoken to local, regional, national, and international professional audiences on the clinical application of CGM.
is first author on 2 research studies on CGM: Argento et al, Hemoglobin A1c, Mean Glucose, and Persistence of Glycation Ratios in Insulin-Treated Diabetes.
Endocrine Practice 2014; 20 (3): 252-260, and Argento
and Nakamura, Real Time Personal Continuous Glucose Monitoring in Patients 65 Years and Older, Endocrine Practice 2014; 20 (12): 1297-1302, and presented CGM results of SGLT-2 use in Type 1 diabetes
at the 76th American Diabetes Association
meetings in June 2015.
was a co-author or contributor to multiple chapters in â€œPutting Your Patient on the Pump, Second Editionâ€�, published by the American Diabetes Association
He was a co-director and presenter for TCOYDâ€™s 2 visits to Washington, DC, has lead a JDRF Walk To Cure Team since 1997, and frequently speaks to local diabetes patient groups.